Darvocet (Dextropropoxyphene) 100 mg: Uses, Risks and Safety, and Important Information

Darvocet is a brand name that has historically been associated with dextropropoxyphene, an opioid painkiller. Dextropropoxyphene has been used to treat pain, both short-term and chronic. But there are big safety issues, such as the chance of a serious or fatal overdose. The European Medicines Agency (EMA) concluded that medicines containing dextropropoxyphene had limited benefit and that the risks outweighed the benefits.

What Is Dextropropoxyphene?

Dextropropoxyphene is a weak opioid analgesic that works by attaching to opioid receptors in the brain and spinal cord to reduce the feeling of pain. It was marketed as a prescription medicine, either by itself or in combination with other ingredients such as paracetamol.

It has a historical use for pain, but the use has dropped off substantially due to safety concerns. For example, dextropropoxyphene has a narrow therapeutic index, which means the range between a dose that may be effective and a dose that may be harmful can be relatively small.

Uses of Darvocet 100 mg:

Traditionally, medicines containing dextropropoxyphene were prescribed for pain management. They were used by doctors for acute or chronic pain depending on the formulation and the country.

However, patients should not assume that an old prescription or product listing means the medicine is still an appropriate treatment today. The EMA concluded that dextropropoxyphene provided little additional benefit in terms of pain relief compared to current options.

Strength 100 mg Important Information

100 mg strength should not be used as a recommended dose. The right amount, formulation and treatment schedule will depend on the specific product and the clinical circumstances. Dextropropoxyphene can be very toxic in overdose and people should not change the amount they take, or restart an old prescription, without consulting a doctor.

Why was dextropropoxyphene withdrawn from the market?

“The regulatory action was taken primarily for safety reasons.

The EMA looked at dextropropoxyphene-containing medicines and found evidence of significant deaths associated with overdose. Importantly, some overdoses were accidental, not intentional. The review also found that proposed measures such as further warnings and restrictions were not considered to be sufficient to reduce the risk to an acceptable level.

The marketing authorisations for non-parenteral dextropropoxyphene medicines should be withdrawn throughout the European Union, following review by the EMA. The European Commission adopted its final decision in June 2010.

Side Effects and Risks of Dextropropoxyphene

Dextropropoxyphene is an opioid and may cause opioid-related adverse effects. Potential problems:

• Sleepiness and dizziness
• Vomiting or nausea
• Constipation .
• Disarray
• Over-sedation
• Respiration depression
• Serious heart effects in overdose

The biggest problem is overdosing. Regulatory assessments found opioid-related respiratory depression and cardiac arrhythmias to be potentially life-threatening effects.

Overdose can quickly become life threatening

There have been reports of potentially fatal overdose with dextropropoxyphene , even in accidental overdose . Suspected poisoning requires a rapid assessment by medical personnel, not the waiting for symptom resolution.

Drug Interactions and Safety

Dextropropoxyphene can react with other drugs and chemicals that depress the central nervous system. When opioids are taken in combination with alcohol, sedatives or other drugs that cause respiratory depression, the risk of dangerous sedation and breathing problems can be increased.

Before you start taking an opioid medication, you need to tell your doctor or chemist about all medicines, supplements, and other substances you take.

Is Darvocet Still Around?

Availability and legality may vary from country to country. However, medicines containing dextropropoxyphene were withdrawn throughout the European Union after the regulatory safety review.

That means just because a product is posted online or is in an old package, doesn’t mean the product is currently approved, safe or legal to be in a certain location.

How Should Patients Respond?

If you have an old medication that contains dextropropoxyphene, do not begin to take it again on your own. Rather, they should talk to a qualified healthcare professional about safer and currently appropriate options for pain management.

In particular, the EMA recommended that patients taking dextropropoxyphene should discuss their treatment with their doctor and any unused medicines should be returned to a chemist for safe disposal.

Conclusion:

Darvocet and dextropropoxyphene are historically important opioid painkillers but their safety profile shouldn’t be taken lightly. The EMA said the limited benefits in pain relief did not justify the risk of potentially fatal overdose.

Therefore, if you are considering pain treatment, you should discuss current approved alternatives with a healthcare professional and not use an old dextropropoxyphene product without medical supervision.